Breaking Down the New NHS Value Proposition

April 6, 2022

With the growing influence of Integrated Care Systems (ICS) in the UK, the NHS has adjusted their definition of value. This necessitates changes in how ICSs and pharma construct their value propositions. The new changes mean companies must highlight 5 forms of value for patients, preventative value, social value, service value, experiential value, and efficiency value. Additionally, organizations are responsible for addressing health inequities.

According to a new PM Live article, “Pharma can add considerable value by helping the NHS understand the nature of under-served and under-treated patient groups (not just in cancer but across all long-term conditions). The data, analysis and insight pharmaceutical companies hold can help identify and stratify these missing patients, drawing out the cost arguments associated with late presentation and showing how it can complement NHS efforts to minimise them.”

To read more, click here.

(Source: PM Live, April 6th, 2022)

Share This Story!